Videos & Animations
Eluvia Drug-Eluting Vascular Stent
EMINENT Trial: Eluvia DES vs BMS
Watch Prof. Y. Goueffic (Vascular Surgeon, France) presents the 12-Month results of the EMINENT RCT.
IMPERIAL Trial: First of its Kind Design
Physicians provide an overview of the trial’s unique design, including the Eluvia DES and how investigators sought to improve on prior technologies.
Impact of the IMPERIAL Trial
Hear physician commentary on how the IMPERIAL Trial’s level 1 evidence is influencing their clinical and economic decisions.
IMPERIAL Trial: Influencing Treatment Algorithms
See how IMPERIAL Trial results may help physicians make recommendations on which forms of antiproliferative therapies are best for each patient.
The Challenge
Hear what physicians have to say about the challenges of treating the SFA and how drug-eluting stents may help improve patient outcomes.
The Solution
Physicians talk about the importance of drug-eluting stents in complex lesions and how the Eluvia Drug-Eluting Stent is fine-tuned to produce a sustainable release of paclitaxel over time.
The Heritage
See how over a decade of research helped Eluvia engineers develop the first drug-eluting stent for the SFA designed to sustain drug release when restenosis is most likely.
The Data
See what physicians are saying about the unprecedented clinical outcomes for the Eluvia Drug-Eluting Stent, including two-year primary patency and TLR rates.
The Challenges of the SFA
Find out how the challenging biological environment, mechanical issues and timing of disease progression impact treatment of the SFA.
The Design of the Eluvia Drug-Eluting Stent System
Discover how the Eluvia Drug-Eluting Stent was designed to match the restenotic cascade for better healing and patency in the superficial femoral arteries (SFA).
Stay Up to Date
Receive emails about the latest drug-eluting technology news, innovations and events in your area.